Korean J Obstet Gynecol.  2012 Jun;55(6):378-383. 10.5468/KJOG.2012.55.6.378.

25-hydroxyvitamin D levels and body mass index in healthy postmenopausal women

Affiliations
  • 1Department of Obstetrics and Gynecology, Kosin University College of Medicine, Busan, Korea. hykyale@yahoo.com
  • 2Department of Obstetrics and Gynecology, Konkuk University School of Medicine, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyungkwan University School of Medicine, Changwon, Korea.
  • 5Institute of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan, Korea.

Abstract


OBJECTIVE
Obesity is associated with alterations in vitamin D (VtD) system. We evaluated the correlation between VtD level and body mass index (BMI), a standard for the evaluation of obesity in postmenopausal women.
METHODS
To study the relationship between VtD levels and obesity, we recruited 310 healthy postmenopausal women between January 2005 and March 2011 and analyzed the correlation between BMI and serum 25-hydroxyvitamin D (25-OH-VtD) level. We also analyzed the relationship between serum VtD level and bone health status such as bone mineral density measured by dual-energy X-ray absorptiometry, bone turnover marker, and parathyroid hormone (PTH).
RESULTS
With a cut-off level for VtD deficiency at 30 ng/mL, 98.9% patients showed a VtD deficiency, while 87.8% patients showed a vitamin D deficiency with a 20-ng/mL cut-off level. VtD levels had no significant correlation with age, height, weight, BMI, or bone turnover markers. PTH level and serum 25-OH-VtD level showed a negative correlation. VtD level showed negative correlation with BMI, but statistically not significant.
CONCLUSION
In this study, most of postmenopausal women (more than 87.8%) had a VtD deficiency, and VtD level showed negative correlation with BMI, but was not statistically significant.

Keyword

Vitamin D; Body mass index; Obesity; Postmenopause

MeSH Terms

Absorptiometry, Photon
Body Mass Index
Bone Density
Female
Humans
Obesity
Parathyroid Hormone
Postmenopause
Vitamin D
Vitamin D Deficiency
Parathyroid Hormone
Vitamin D

Cited by  1 articles

Effects of calcium and vitamin D intake level on lipid metabolism in growing rats
Sun-Min Lee, Yeon-Joo Lee, Eun-Sook Won, Sang-Sun Lee
J Nutr Health. 2014;47(2):89-98.    doi: 10.4163/jnh.2014.47.2.89.


Reference

1. Lumb GA, Mawer EB, Stanbury SW. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man. Am J Med. 1971. 50:421–444.
2. Rosenstreich SJ, Rich C, Volwiler W. Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest. 1971. 50:679–687.
3. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972. 43:413–431.
4. Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984. 74:1540–1544.
5. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988. 43:199–201.
6. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000. 72:690–693.
7. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics. 2009. 123:797–803.
8. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006. 81:353–373.
9. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997. 7:439–443.
10. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001. 86:1212–1221.
11. National Heart, Lung, and Blood Institute Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in aults: The Evidence Report. 1998. Bethesda (MD): National Heart, Lung, and Blood Institute.
12. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004. 80:1678S–1688S.
13. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004. 80:1706S–1709S.
14. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985. 76:370–373.
15. Andersen T, McNair P, Fogh-Andersen N, Nielsen TT, Hyldstrup L, Transbol I. Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism. 1986. 35:147–151.
16. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol. 2011. 91:115–124.
17. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003. 88:157–161.
18. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G. A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol (Oxf). 2010. 73:581–587.
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr